Partners International L P Galen III's Net Worth

$5.86 Million

Estimate Recalculated Sep 8, 2024 07:33PM EST

Who is Partners International L P Galen III?

Partners International L P Galen III has an estimated net worth of $5.86 Million. This is based on reported shares across multiple companies, which include MEDASSETS INC, ACURA PHARMACEUTICALS, INC, SPECIALIZED HEALTH PRODUCTS INTERNATIONAL INC, DERMA SCIENCES, INC., ENCORE MEDICAL CORP, and ESSENTIAL GROUP INC.

SEC CIK

Partners International L P Galen III's CIK is 0001034574

Past Insider Trading and Trends

2003 was Partners International L P Galen III's most active year for acquiring shares with 2 total transactions. Partners International L P Galen III's most active month to acquire stocks was the month of July. 2003 was Partners International L P Galen III's most active year for disposing of shares, totalling 3 transactions. Partners International L P Galen III's most active month to dispose stocks was the month of September. 2003 saw Partners International L P Galen III paying a total of $971,244.00 for 997,649 shares, this is the most they've acquired in one year. In 2006 Partners International L P Galen III cashed out on 834,204 shares for a total of $5,464,036.20, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

MEDASSETS INC No price found

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.54%
-30.86K
$24.11
-$743,818.57
5.67M
Scheduled
May 17 - May 18
Form 4
-1.92%
-111.71K
$22.24
-$2,484,227.16
5.71M
Scheduled
Apr 22 - Apr 26
Form 4
-0.72%
-42.37K
$22.13
-$937,615.00
5.82M
Scheduled
Mar 19 - Mar 23
Form 4
-0.15%
-8.82K
$22.06
-$194,533.89
5.86M
Scheduled
Mar 16 - Mar 18
Form 4
-0.94%
-55.58K
$22.11
-$1,228,962.24
5.87M
Scheduled
Nov 2
Form 4
-1.01%
-60.31K
$22.06
—
5.92M
Scheduled
Oct 8 - Oct 9
Form 4
-0.17%
-10.05K
$22.06
-$221,636.82
5.98M
Scheduled
Oct 5 - Oct 6
Form 4
-4.21%
-263.61K
$22.12
—
5.99M
Scheduled
Oct 1 - Oct 2
Form 4
-0.88%
-55.85K
$22.19
-$1,239,154.50
6.26M
Scheduled
Sep 15
Form 4
-0.15%
-55.85K
$19.00
-$1,061,150.00
38.02M
Scheduled
Aug 3
Form 4
-0.15%
-55.85K
$19.16
-$1,070,162.64
38.36M
Scheduled
Jul 1
Form 4
-0.14%
-55.85K
$17.06
-$952,869.24
38.7M
Scheduled
Jun 10
Form 4
-0.14%
-55.85K
$16.36
-$913,771.44
39.03M
Scheduled
May 1
Form 4
-0.41%
-335.12K
$16.25
-$5,490,793.92
81.09M
Scheduled
Apr 22 - Apr 23
Form 4/A
-0.04%
-55.85K
$16.49
-$922,250.85
125.14M
Scheduled
Sep 11 - Sep 15
Form 4
-0.05%
-55.85K
$16.19
-$901,474.11
124.06M
Scheduled
Oct 1 - Oct 3
Form 4
-0.06%
-55.85K
$16.49
-$922,250.85
97.13M
Scheduled
Sep 11 - Sep 15
No matching records found

ACURA PHARMACEUTICALS, INC (ACUR) Snapshot price: $0.05

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-2.20M
$0.10
-$219,573.40
0
Dec 14
Form 4
-0.95%
-104.82K
$1.08
-$113,535.90
10.98M
Jun 16 - Jun 17
Form 4/A
-1.52%
-171.00K
$0.62
-$106,072.00
11.08M
Jan 8 - Jan 12
Form 4
-1.54%
-171.00K
$0.62
-$106,072.00
10.96M
Jan 8 - Jan 12
Form 4/A
-0.19%
-21.60K
$2.01
-$43,320.65
11.26M
Feb 28
Form 4
-0.02%
-2.50K
$2.00
-$5,000.00
11.13M
Mar 3
Form 4
-3.06%
-351.26K
$2.02
-$710,769.28
11.13M
Feb 26 - Feb 28
Form 4
-0.38%
-44.02K
$1.97
-$86,554.50
11.48M
Feb 21 - Feb 24
Form 4
-0.02%
-2.20K
$1.95
-$4,290.00
11.53M
Feb 18
Form 4
-0.04%
-4.20K
$2.05
-$8,610.00
11.53M
Oct 10
Form 4
-1.70%
-200.00K
$2.15
-$430,000.00
11.53M
Jul 2
Form 4
-0.17%
-20.45K
$2.15
-$43,958.90
11.73M
Jun 17
Form 4
-0.27%
-31.28K
$2.16
-$67,431.90
11.75M
Jun 12 - Jun 14
Form 4
-0.18%
-21.50K
$2.20
-$47,270.24
11.78M
Jun 7 - Jun 10
Form 4
-0.33%
-39.45K
$2.19
-$86,391.05
11.81M
Jun 4 - Jun 6
Form 4
-0.27%
-31.56K
$2.25
-$71,084.91
11.85M
May 30 - May 31
Form 4
-0.40%
-47.41K
$2.30
-$108,976.63
11.88M
May 21
Form 4
-1.37%
-166.05K
$2.33
-$387,615.43
11.92M
May 16 - May 20
Form 4
-1.49%
-183.43K
$2.33
-$426,890.23
12.09M
May 13 - May 15
Form 4
-1.23%
-153.30K
$2.16
-$331,494.30
12.33M
May 3 - May 7
Form 4
-1.38%
-174.76K
$2.41
-$421,619.06
12.49M
Apr 30 - May 2
Form 4
-0.44%
-56.34K
$2.59
-$145,870.08
12.66M
Apr 25 - Apr 29
Form 4
-1.84%
-238.76K
$3.20
-$765,093.60
12.72M
Apr 17
Form 4
-0.30%
-39.30K
$2.14
-$84,279.36
12.96M
Apr 12 - Apr 16
Form 4
-0.93%
-121.45K
$2.23
-$270,380.03
13M
Apr 10 - Apr 11
Form 4
-1.51%
-200.49K
$2.16
-$432,148.80
13.12M
Apr 5 - Apr 9
No matching records found

SPECIALIZED HEALTH PRODUCTS INTERNATIONAL INC No price found

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-91.73%
-15.38M
$1.00
-$15,376,413.00
1.39M
Jun 6
No matching records found

DERMA SCIENCES, INC. No price found

Investor

Partners International L P Galen III owns 133,777 units of Common Stock. In the year 2007 Partners International L P Galen III filed a total of 1 filing.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+27.83%
29.12K
$0.78
$22,707.20
133.78K
Jan 5
No matching records found

ENCORE MEDICAL CORP No price found

Investor

Partners International L P Galen III used to own units in Common Stock but no longer holds any shares there. In the year 2003 Partners International L P Galen III filed a total of 7 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-834.20K
$6.55
-$5,464,036.20
0
Oct 20 - Nov 3
Form 4
+5.76%
45.45K
$0.01
$454.49
834.2K
Oct 20
Form 4
-9.89%
-86.55K
$6.25
-$540,912.50
788.75K
Dec 18
Form 4
-13.48%
-136.33K
$6.25
-$852,075.00
875.3K
Dec 16
Form 4
—
0
—
—
0
Aug 14
Form 4
+1,602.14%
952.2K
$1.02
$971,244.00
1.01M
Aug 11
Form 3
—
0
—
—
0
No matching records found